https://www.selleckchem.com/products/fht-1015.html
Current assays based on the 0-hour/1-hour (0-/1-h) algorithm using high-sensitivity cardiac troponin (hs-cTn) are limited to only Abbott Architect hs-cTnI, Siemens Vista hs-cTnI, and Roche Elecsys hs-cTnT. This study aimed to evaluate this new hs-cTnI assay, LumipulsePresto hs Troponin I, for diagnosis of acute myocardial infarction (AMI) on admission and on 0-/1-h algorithm to stratify AMI patients precisely. This prospective cohort study included 442 patients with suspected non-ST-elevation myocardial infarction in three hospitals in
Gefällt mir
Kommentar
Teilen
